Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B. B. Mursalov"'
Autor:
K. V. Zhdanov, K. V. Kozlov, K. V. Kas’janenko, S. M. Zakharenko, V. S. Sukachev, N. I. L’vov, O. V. Mal’tsev, D. V. Lavrenchuk, I. I. Lapikov, V. V. Sharabhanov, R. M. Mukhtarov, M. A. Bulygin, V. G. Potapenko, E. A. Malikova, M. N. Nepomnjashchikh, B. B. Mursalov, A. R. Sheraliev, M. Yu. Pervakova, S. V. Lapin
Publikováno v:
Журнал инфектологии, Vol 12, Iss 3, Pp 34-41 (2020)
Aim. In this study we evaluated clinical effectiveness and safety of nebulized prostacyclin in patients with Novel Coronavirus Disease (SARS-CoV-2). Materials and methods: We have included 44 male patients with moderate PCR confirmed SARS-CoV-2 infec
Externí odkaz:
https://doaj.org/article/aee2a67480054280af3b259e3c2b573b
Autor:
I. I. Lapikov, M. N. Nepomnjashchikh, D. V. Lavrenchuk, K. V. Kozlov, O. V. Mal’tsev, Sergey V. Lapin, V. V. Sharabhanov, B. B. Mursalov, VG Potapenko, V. S. Sukachev, M A Bulygin, K. V. Zhdanov, M Yu Pervakova, E. A. Malikova, R. M. Mukhtarov, N. I. L’vov, K. V. Kas’janenko, S. M. Zakharenko, A. R. Sheraliev
Publikováno v:
Žurnal Infektologii, Vol 12, Iss 3, Pp 34-41 (2020)
Aim. In this study we evaluated clinical effectiveness and safety of nebulized prostacyclin in patients with Novel Coronavirus Disease (SARS-CoV-2). Materials and methods: We have included 44 male patients with moderate PCR confirmed SARS-CoV-2 infec